4.87
-0.14(-2.79%)
Currency In USD
| Previous Close | 5.01 |
| Open | 5.05 |
| Day High | 5.29 |
| Day Low | 4.78 |
| 52-Week High | 21.98 |
| 52-Week Low | 3 |
| Volume | 121,659 |
| Average Volume | 171,433 |
| Market Cap | 90.28M |
| PE | -1.78 |
| EPS | -2.74 |
| Moving Average 50 Days | 4.11 |
| Moving Average 200 Days | 7.28 |
| Change | -0.14 |
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
GlobeNewswire Inc.
Jan 27, 2026 2:00 PM GMT
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
GlobeNewswire Inc.
Jan 26, 2026 9:05 PM GMT
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will rel
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:30 PM GMT
Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and co